Transforming growth factor-beta 1 (TGF-beta 1) has been implicated to play
an important, role both in the process of normal development and in the pat
hogenesis of a wide variety of disease processes, including those of the ki
dney. TGF-beta 1 regulates diverse cellular functions via a heteromeric sig
naling complex of two transmembrane serine/threonine kinase receptors (type
s I and II). Several distinct type I receptors have been described and are
thought to determine specificity of the TGF-beta response and confer multif
unctionality. This report reveals the cloning of a novel, naturally occurri
ng soluble form of TGF-beta type I receptor, designated sT beta R-I, from a
rat kidney cDNA library. In vivo expression of a mRNA transcript encoding
the sT beta R-I, which lacks the transmembrane and cytoplasmic domains, is
confirmed by RT-PCR followed by Southern blot analysis and by RNase protect
ion assay. The sT beta R-I mRNA abundance is greater in the neonatal rat ki
dney compared with the adult rat kidney. Furthermore, sT beta R-I is a func
tional protein capable of binding TGF-beta 1 ligands in the presence of a T
GF-beta type II receptor on the cell surface, as determined by affinity cro
ss-linking with I-125-labeled TGF-beta 1. Studies using p3TP-Lux reporter c
onstruct reveal that this novel protein may function as a potentiator of TG
F-beta signaling. The discovery of a sT beta R-I provides an additional lev
el of complexity to the TGF-beta receptor system.